Galenica Sustainability and Business Performance slide image

Galenica Sustainability and Business Performance

About Galenica Market environment Business performance Governance Sustainability Outlook Swiss healthcare market: regulatory environment New proposal for distribution margin The new proposal by the FOPH includes an adjustment of the distribution margin model with uniform margin for medications with the same active ingredient composition (lowest margin). It is open whether this proposal is linked to a new SBR V contract that compensates for the loss of margin. 10 70 60 60 50 50 Current model New proposal Public price 30 30 40 40 20 20 10 10 Ex factory price 5 10 15 20 25 30 35 40 40 In% of sold packs 1) 20.6% 27% 7.6% 1) Source: pharmaSuisse 08/08/22 41.6% (CHF 15 - 199.99) 38 FOPH defines price and margin – Margin covers wholesale and retail - Ex factory price (in CHF) + price-related surcharge + surcharge per pack 0.05 13.99 9.0% 7.00 14.00 23.99 9.0% 12.00 24.00 999.99 9.0% 16.00 - 1'000 3'130.99 9.0% 19.00 From 3'131 300.00 GALENICA
View entire presentation